Discovery II Study
- Conditions
- Colorectal carcinoma, colorectal polyps, colorectal adenomas
- Registration Number
- NL-OMON22821
- Lead Sponsor
- Radboudumc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 560
Inclusion Criteria
= 18 years;
-Referred and scheduled for diagnostic, screening (non-iFOBT based) or surveillance colonoscopy.
Exclusion Criteria
-Known colorectal tumor or polyp on referral;
-Referral for a therapeutic procedure (i.e. endoscopic resection, intervention for lower gastro-intestinal bleeding, etc.);
-Inadequately corrected anticoagulation disorders or anticoagulation medication use;
-American Society of Anesthesiologists (ASA) score ? 3;
-Inability to provide informed consent;
-Known or suspected inflammatory bowel disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adenoma detection rate (ADR)
- Secondary Outcome Measures
Name Time Method